DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cloranolol
Cloranolol
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
(12) United States Patent (10) Patent No.: US 8,080,578 B2 Liggett Et Al
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Self-Measured Compared to Office
Multimedia Appendix 1. Search Strategy Developed for Medline Via Ovid to Identify Existing Systematics Review. Concept 1: BP
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
A Study on Beta Blockers - a Brief Review Tv
Stembook 2018.Pdf
SUPPLEMENTARY MATERIAL 1: Search Strategy
2021 Equine Prohibited Substances List
Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration
Effects of Pharmacological Exposure on Ovarian Cancer (EPOC)
Review 0103 - 5053 $6.00+0.00
WO 2014/170786 Al 23 October 2014 (23.10.2014) P O P C T
Pharmaceuticals Appendix
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Top View
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Beta-Blockers and Inhibitors of the Renin-Angiotensin Aldosterone System for Chronic Heart Failure with Preserved Ejection Fraction (Review)
Statistical Analysis Plan: 20140254 Date: 07 January 2017 Page 24
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Drug-Resin Complexes Stabilized by Chelating Agents
(12) United States Patent (10) Patent No.: US 8,414.914 B2 Bromley Et Al
First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
Medications, Dry Mouth and Dental Caries Among Older People: a Longitudinal Study
Progress in the Enantioseparation of -Blockers by Chromatographic Methods
2019 Banned Substances List.Pdf
(12) Patent Application Publication (10) Pub. No.: US 2008/0300292 A1 Letts Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmacotherapy for Hypertension in Adults Aged 18 to 59 Years (Review)
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Pharmaceutical Appendix to the Tariff Schedule 2
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
An Application to Include Blood Pressure Lowering Drug Fixed Dose
Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies
Beta-Blockers and Inhibitors of the Renin-Angiotensin Aldosterone System for Chronic Heart Failure with Preserved Ejection Fraction (Review)
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
Supplementary Online Content
Identification and Characterization of Antidiabetic And
Non-Interventional Study Protocol
(12) United States Patent (10) Patent No.: US 7,838,552 B2 Davis Et Al
ATC Code Title
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Validation of Rapid UPLC/MS/MS Qualitative Screening Method for Detection of Β-Blockers in Urine Samples